TCR cell therapies vanquish solid tumors — finally
Nature Biotechnology, Published online: src2 October 2src24; doi:1src.1src38/s41587-src24-src2435-5The FDA’s approval of the first genetically modified T cell therapy for treating a rare sarcoma is paving the way for next-generation therapies that tackle other types of solid tumors…
Nature Biotechnology, Published online: src2 October 2src24; doi:1src.1src38/s41587-src24-src2435-5The FDA’s approval of the first genetically modified T cell therapy for treating a rare sarcoma is paving the way for next-generation therapies that tackle other types of solid tumors…
Read More
About Author
